Электронный архив

Modern methods of preclinical anticancer drug screening using test systems based on cell cultures

Показать сокращенную информацию

dc.contributor.author Kitaeva K.V.
dc.contributor.author Rizvanov A.A.
dc.contributor.author Solovyeva V.V.
dc.date.accessioned 2022-02-09T20:48:54Z
dc.date.available 2022-02-09T20:48:54Z
dc.date.issued 2021
dc.identifier.issn 2542-064X
dc.identifier.uri https://dspace.kpfu.ru/xmlui/handle/net/170475
dc.description.abstract Preclinical screening of medicinal drugs for novel anti-cancer treatments faces a problem of a rational approach to primary screening of substances with antitumor activity. Low correlation between in vitro and in vivo studies with clinical trials remains a serious issue. Choosing the right tumor model at the in vitro testing stage reduces the financial and time costs of finding and testing promising antitumor agents. In the light of the growing prevalence of cancer, it is urgently important to develop new approaches to screening of anticancer drugs, as well as to increase the pace of creation, development, and testing of new antitumor agents. Although the pharmaceutical industry uses mainly two-dimensional in vitro models, the field of preclinical screening needs more complex models, such as three-dimensional models, microfluidic systems, Boyden chamber, and models created using three-dimensional bioprinting. This review describes the above in vitro tumor models, including their use in research and features, in order to help researchers and clinicians from various fields of pharmacy, preclinical studies, and cell biology understand their prospects for screening potential antitumor drugs.
dc.relation.ispartofseries Uchenye Zapiski Kazanskogo Universiteta. Seriya Estestvennye Nauki
dc.subject 3D bioprinting
dc.subject Antitumor drug screening
dc.subject Boyden chamber
dc.subject In vitro tumor model
dc.subject Microfluidic systems
dc.subject Three-dimensional cultures
dc.subject Tumor microenvironment
dc.subject Two-dimensional cultures
dc.title Modern methods of preclinical anticancer drug screening using test systems based on cell cultures
dc.type Article
dc.relation.ispartofseries-issue 2
dc.relation.ispartofseries-volume 163
dc.collection Публикации сотрудников КФУ
dc.relation.startpage 155
dc.source.id SCOPUS2542064X-2021-163-2-SID85116889432


Файлы в этом документе

Данный элемент включен в следующие коллекции

  • Публикации сотрудников КФУ Scopus [24551]
    Коллекция содержит публикации сотрудников Казанского федерального (до 2010 года Казанского государственного) университета, проиндексированные в БД Scopus, начиная с 1970г.

Показать сокращенную информацию

Поиск в электронном архиве


Расширенный поиск

Просмотр

Моя учетная запись

Статистика